Çocuklarda Huntington Hastalığı için Potansiyel Kan Biyomarkörü Olarak Nörofilament Hafif Protein.
Neurofilament Light Protein as a Potential Blood Biomarker for Huntington's Disease in Children.
DOI: 10.1002/mds.29027PMID: 35437792
Neurofilament Light Protein as a Potential Blood Biomarker for Huntington's Disease in Children.
DOI: 10.1002/mds.29027PMID: 35437792
Amyloid β, Tau, and α-Synuclein aggregates in the pathogenesis, prognosis, and therapeutics for neurodegenerative diseases.
DOI: 10.1016/j.pneurobio.2022.102270PMID: 35447272
Beneficial Role of Vitexin in Parkinson's Disease.
DOI: 10.21315/mjms2023.30.2.2PMID: 37102042
ER Stress in COVID-19 and Parkinson's Disease: In Vitro and In Silico Evidences.
DOI: 10.3390/brainsci12040507PMID: 35448038
Anti-Inflammatory and Neuroprotective Mechanisms of GTS-21, an α7 Nicotinic Acetylcholine Receptor Agonist, in Neuroinflammation and Parkinson's Disease Mouse Models.
DOI: 10.3390/ijms23084420PMID: 35457238
Quality of life predicts rehabilitation prognosis in Parkinson's disease patients: Factors influence rehabilitation prognosis: Factors influence rehabilitation prognosis.
DOI: 10.1002/brb3.2579PMID: 35429406
Effects of Rhythmic Auditory Stimulation on Gait and Motor Function in Parkinson's Disease: A Systematic Review and Meta-Analysis of Clinical Randomized Controlled Studies.
DOI: 10.3389/fneur.2022.818559PMID: 35493833
Alterations of Striatal Subregions in a Prion Protein Gene V180I Mutation Carrier Presented as Frontotemporal Dementia With Parkinsonism.
DOI: 10.3389/fnagi.2022.830602PMID: 35493933
Recent Trends and Practices Toward Assessment and Rehabilitation of Neurodegenerative Disorders: Insights From Human Gait.
DOI: 10.3389/fnins.2022.859298PMID: 35495059
The Impact of Triangle Hierarchical Management on Self-Management Behavior and Quality of Survival in Parkinson's Patients.
DOI: 10.3389/fsurg.2022.878477PMID: 35495769
Body Mass Index and Exercise Effort Influences Changes in Motor Symptoms After High-Cadence Dynamic Cycling in Parkinson's Disease.
DOI: 10.3389/fresc.2022.858401PMID: 36189060
Anti-Parkinsonian Therapy: Strategies for Crossing the Blood-Brain Barrier and Nano-Biological Effects of Nanomaterials.
DOI: 10.1007/s40820-022-00847-zPMID: 35426525
Kayıtlar bilimsel kaynaklardan alınır. Bibliyografik kayıt sayısı, Türkçe çeviri veya editoryal onay sayısı değildir.